Abstract:The revolutionary CRISPR/Cas9 gene editing technology holds immense potential for treating genetic diseases and tackling conditions like cancer. However, efficient delivery remains a significant challenge. This is where nanoparticles come into play, emerging as powerful allies in the realm of drug delivery. Nanoparticles can accommodate larger insertion sizes, enabling the incorporation of larger Cas9 enzymes and complex guide RNAs, thus opening up the possibility of editing previously inaccessible genetic regions. Their relatively straightforward and scalable production processes make them cost-effective options for wider applications. Notably, nanoparticles excel in vivo, demonstrating efficient tissue penetration and targeted delivery, which are crucial for maximizing therapeutic impact while minimizing side effects. This review aims to explore the potential of nanoparticle-based delivery systems for CRISPR/Cas9, highlighting their advantages and challenges in gene editing applications. The diverse range of nanoparticles further bolsters their potential. Polymeric nanoparticles, for instance, offer tunable properties for customization and controlled release of the CRISPR cargo. Lipid-based nanoparticles facilitate efficient cellular uptake and endosomal escape, ensuring the CRISPR components reach the target DNA. Even gold nanoparticles, known for their unique biocompatibility and photothermal properties, hold promise in light-activated editing strategies. Non-viral delivery systems, particularly those based on nanoparticles, stand out due to their inherent advantages. Collectively, the evidence paints a promising picture: nanoparticles are not merely passive carriers but active participants in the CRISPR/Cas9 delivery landscape. Their versatility, efficiency, and safety position them as key enablers of a future where gene editing can revolutionize drug development, offering personalized and targeted therapies for a wide range of diseases.

Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing

Non-viral Nanocarriers for CRISPR-Cas9 Gene Editing System Delivery

Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics

Nano-vectors for CRISPR/Cas9-mediated genome editing

Challenges in Crispr/Cas9 Delivery: Potential Roles of Nonviral Vectors

Lipid‐, Inorganic‐, Polymer‐, and DNA‐Based Nanocarriers for Delivery of the CRISPR/Cas9 System

Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

Lipid, Inorganic, Polymer, and DNA Based Nanocarriers for Delivery of CRISPR/Cas9 System

Nanotechnology Based CRISPR/Cas9 System Delivery for Genome Editing: Progress and Prospect

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities

Latest Progress in the Study of Nanoparticle-Based Delivery of the CRISPR/Cas9 System.

Nanoparticle Carriers: A New Era of Precise CRISPR/Cas9 Gene Editing.

Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems

Key Considerations in Designing CRISPR/Cas9-carrying Nanoparticles for Therapeutic Genome Editing.

Key Considerations In Designing Crispr/Cas9-Carrying Nanoparticles For Therapeutic Genome Editing

Lipids and Polymers Mediated CRISPR/Cas9 Gene Editing

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems

Nanoparticles‐Mediated CRISPR/Cas Gene Editing Delivery System

Synthetic Vehicles for Encapsulation and Delivery of CRISPR/Cas9 Gene Editing Machinery